United States HR 5239: Prescription Drug Price Reporting Act

Status: Referred to the Subcommittee on Health. (as of 2019-11-22)

State: United States · Session: 116 · Bill: HR 5239

Subjects: Business records, Federal preemption, Government information and archives, Health care costs and insurance, Inflation and prices, Prescription drugs, Retail and wholesale trades, State and local government operations

Sponsors: David P. Joyce, Anthony Gonzalez

View United States HR 5239 on LegisTrack → — full text, sponsors, votes, campaign finance, and cross-state matches.